🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the makers of Tylenol, claiming the corporations withheld potential risks that the pain reliever created to children's neurological development.

This legal action arrives a month after Donald Trump advocated an unverified association between using Tylenol - also known as acetaminophen - throughout gestation and autism in children.

The attorney general is filing suit against Johnson & Johnson, which formerly manufactured the drug, the exclusive pain medication suggested for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he said they "deceived the public by profiting off of pain and pushing pills without regard for the potential hazards."

Kenvue states there is lacking scientific proof linking Tylenol to autism.

"These corporations lied for decades, deliberately risking countless individuals to increase profits," Paxton, from the Republican party, stated.

The manufacturer stated officially that it was "seriously troubled by the spread of false claims on the security of acetaminophen and the potential impact that could have on the well-being of US mothers and children."

On its online platform, the company also said it had "consistently assessed the relevant science and there is lacking reliable evidence that shows a verified association between using paracetamol and autism."

Organizations acting on behalf of doctors and health professionals share this view.

ACOG has said acetaminophen - the primary component in acetaminophen - is a restricted selection for expectant mothers to address discomfort and fever, which can present significant medical dangers if ignored.

"In over twenty years of investigation on the consumption of paracetamol in pregnancy, zero credible investigations has successfully concluded that the use of acetaminophen in any stage of gestation causes neurological conditions in children," the organization stated.

The lawsuit mentions recent announcements from the previous government in arguing the drug is allegedly unsafe.

In recent weeks, Trump raised alarms from health experts when he advised women during pregnancy to "struggle intensely" not to take acetaminophen when unwell.

Federal regulators then issued a notice that physicians should think about restricting the consumption of acetaminophen, while also stating that "a direct connection" between the medication and autism spectrum disorder in young ones has not been proven.

The Health Department head Kennedy, who supervises the FDA, had vowed in April to undertake "comprehensive study program" that would determine the cause of autism in a short period.

But authorities warned that identifying a unique factor of autism spectrum disorder - thought by researchers to be the result of a complex mix of inherited and environmental factors - would not be simple.

Autism spectrum disorder is a type of permanent neurological difference and impairment that impacts how persons encounter and interact with the world, and is identified using medical professional evaluations.

In his lawsuit, the attorney general - aligned with the former president who is campaigning for US Senate - asserts Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the companies "remove any commercial messaging" that asserts acetaminophen is safe for pregnant women.

The Texas lawsuit echoes the complaints of a group of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in two years ago.

The court rejected the case, saying investigations from the parents' expert witnesses was not conclusive.